Synthetic intron improves transduction efficiency of trans-splicing adeno-associated viral vectors

Human Gene Therapy

Volumn 17, Issue 10, 2006, Pages 1036-1042

  Lai, Yi ^a   Yue, Yongping ^a   Liu, Mingju ^a   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; DYSTROPHIN; MESSENGER RNA; PARVOVIRUS VECTOR; RIBONUCLEASE; RNA;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXON; GENE EXPRESSION; GENE THERAPY; INTRON; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA SPLICING; RNA SYNTHESIS; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION; VIRUS GENOME;

ANIMALS; DEPENDOVIRUS; DYSTROPHIN; GENETIC VECTORS; INTRONS; MALE; MICE; MICE, INBRED MDX; MUSCLE, SKELETAL; RNA PRECURSORS; RNA, MESSENGER; TRANS-SPLICING; TRANSDUCTION, GENETIC;

EID: 33846171622     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.1036     Document Type: Article

References (24)

1. CAROTHERS, A.M., URLAUB, G., GRUNBERGER, D., and CHASIN, L.A. (1993). Splicing mutants and their second-site suppressors at the dihydrofolate reductase locus in Chinese hamster ovary cells. Mol. Cell. Biol. 13, 5085-5098.
2. CARTER, B.J. (2004). Adeno-associated virus and the development of adeno-associated virus vectors: A historical perspective. Mol. Ther. 10, 981-989.
3. CARTER, B.J. (2005). Adeno-associated virus vectors in clinical trials. Hum. Gene Ther. 16, 541-550.
4. CHAMBERLAIN, J.S. (2002). Gene therapy of muscular dystrophy. Hum. Mol. Genet. 11, 2355-2362.
5. DONG, J.Y., FAN, P.D., and FRIZZELL, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2101-2112.
6. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol. Ther. 4, 383-391.
7. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2003). Dual vector expansion of the recombinant AAV packaging capacity. Methods Mol. Biol. 219, 29-51.
8. FLOTTE, T.R. (2005). Adeno-associated virus-mediated gene transfer for lung diseases. Hum. Gene Ther. 16, 643-648.
9. FLOTTE, T.R., and BERNS, K.I. (2005). Adeno-associated virus: A ubiquitous commensal of mammals. Hum. Gene Ther. 16, 401-407.
10. GAO, G., VANDENBERGHE, L.H., and WILSON, J.M. (2005). New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297.
11. GRIEGER, J.C., and SAMULSKI, R.J. (2005). Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps. J. Virol. 79, 9933-9944.
12. LAI, Y., YUE, Y., LIU, M., GHOSH, A., ENGELHARDT, J.F., CHAMBERLAIN, J.S., and DUAN, D. (2005). Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol. 23, 1435-1439.
13. LIU, M., YUE, Y., HARPER, S.Q., GRANGE, R.W., CHAMBERLAIN, J.S., and DUAN, D. (2005). Adeno-associated virus-mediated microdystrophin expression protects young mdx muscle from contraction-induced injury. Mol. Ther. 11, 245-256.
14. MANNO, C.S., ARRUDA, V.R., PIERCE, G.F., GLADER, B., RAGNI, M., RASKO, J., OZELO, M.C., HOOTS, K., BLATT, P., KONKLE, B., DAKE, M., KAYE, R., RAZAVI, M., ZAJKO, A., ZEHNDER, J., NAKAI, H., CHEW, A., LEONARD, D., WRIGHT, J.F., LESSARD, R.R., SOMMER, J.M., TIGGES, M., SABATINO, D., LUK, A., JIANG, H., MINGOZZI, F., COUTO, L., ERTL, H.C., HIGH, K.A., and KAY, M.A. (2006). Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347.
15. NAKAI, H., STORM, T.A., and KAY, M.A. (2000). Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors [see comments]. Nat. Biotechnol. 18, 527-532.
16. REICH, S.J., AURICCHIO, A., HILDINGER, M., GLOVER, E., MAGUIRE, A.M., WILSON, J.M., and BENNETT, J. (2003). Efficient trans-splicing in the retina expands the utility of adenoassociated virus as a vector for gene therapy. Hum. Gene Ther. 14, 37-44.
17. SHAPIRO, M.B., and SENAPATHY, P. (1987). RNA splice junctions of different classes of eukaryotes: Sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15, 7155-7174.
18. SUN, L., LI, J., and XIAO, X. (2000). Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599-602.
19. WANG, L., and HERZOG, R.W. (2005). AAV-mediated gene transfer for treatment of hemophilia. Curr. Gene Ther. 5, 349-360.
20. WARRINGTON, K.H., JR., GORBATYUK, O.S., HARRISON, J.K., OPIE, S.R., ZOLOTUKHIN, S., and MUZYCZKA, N. (2004). Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J. Virol. 78, 6595-6609.
21. XU, Z., YUE, Y., LAI, Y., YE, C., QIU, J., PINTEL, D.J., and DUAN, D. (2004). Trans-splicing adeno-associated viral vector-mediated gene therapy is limited by the accumulation of spliced mRNA but not by dual vector coinfection efficiency. Hum. Gene Ther. 15, 896-905.
22. YAN, Z., ZHANG, Y., DUAN, D., and ENGELHARDT, J.F. (2000). From the cover: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 97, 6716-6721.
23. YAN, Z., ZAK, R., ZHANG, Y., and ENGELHARDT, J.F. (2005). Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes. J. Virol. 79, 364-379.
24. YUE, Y., LI, Z., HARPER, S.Q., DAVISSON, R.L., CHAMBERLAIN, J.S., and DUAN, D. (2003). Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation 108, 1626-1632.